Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
Recruiting · NCT06818474 · Registry updated 2025-02-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lanadelumab in Long-term Prophylaxis of Acquired Angioedema | Hypersensitivity, Immediate, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, immune system disorder, skin disorder, skin vascular disease, urticaria, vascular disorder | Recruiting | Phase 4 | 2025-02-25 | NCT06818474 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bernstein Clinical Research Center | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bernstein Clinical Research Center, LLC | Cincinnati | United States | 6 |